BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 7587243)

  • 1. Standards of evidence for the safety and effectiveness of critical care monitoring devices and related interventions. Coalition for Critical Care Excellence: Consensus Conference on Physiologic Monitoring Devices.
    Crit Care Med; 1995 Oct; 23(10):1756-63. PubMed ID: 7587243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic monitoring devices.
    Alpert S
    Crit Care Med; 1995 Oct; 23(10):1626-7. PubMed ID: 7587226
    [No Abstract]   [Full Text] [Related]  

  • 3. The Food and Drug Administration and atrial defibrillation devices.
    Chen L; Keane AT; Every NR
    Am J Manag Care; 1999 Jul; 5(7):899-909. PubMed ID: 10557410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices.
    Golish SR; Reed ML
    Spine J; 2017 Jan; 17(1):150-157. PubMed ID: 27737804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of medical devices in radiology: current standards and future opportunities.
    Smith JJ
    Radiology; 2001 Feb; 218(2):329-35. PubMed ID: 11161144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices; general hospital and personal use monitoring devices; classification of the ingestible event marker. Final order.
    Food and Drug Administration, HHS
    Fed Regist; 2013 May; 78(95):28733-5. PubMed ID: 23678675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical devices; apnea monitor; special controls. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jul; 67(137):46851-2. PubMed ID: 12125715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the 2016 U.S. Food and Drug Administration Circulatory System Devices Advisory Panel Meeting on the Absorb Bioresorbable Vascular Scaffold System.
    Steinvil A; Rogers T; Torguson R; Waksman R
    JACC Cardiovasc Interv; 2016 Sep; 9(17):1757-64. PubMed ID: 27609249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Who is responsible for evaluating the safety and effectiveness of medical devices? The role of independent technology assessment.
    Feldman MD; Petersen AJ; Karliner LS; Tice JA
    J Gen Intern Med; 2008 Jan; 23 Suppl 1(Suppl 1):57-63. PubMed ID: 18095046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital Health.
    Ronquillo JG; Zuckerman DM
    Milbank Q; 2017 Sep; 95(3):535-553. PubMed ID: 28895231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proposed FDA "unsafe" lead wire ban could affect many medical devices.
    Hosp Technol Ser; 1995 Jul; 14(7):12-4. PubMed ID: 10144657
    [No Abstract]   [Full Text] [Related]  

  • 12. Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs.
    Golish SR
    Trials; 2017 Jul; 18(1):348. PubMed ID: 28738891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting clinical evidence for market authorisation of cardio-vascular devices in Europe and the USA: a systematic analysis of 10 devices based on Austrian pre-reimbursement assessments.
    Wild C; Erdös J; Zechmeister I
    BMC Cardiovasc Disord; 2014 Nov; 14():154. PubMed ID: 25366498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical device regulation for manufacturers.
    McAllister P; Jeswiet J
    Proc Inst Mech Eng H; 2003; 217(6):459-67. PubMed ID: 14702983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than standards and regulations are needed to provide safe and effective devices.
    Levin M
    Biomed Instrum Technol; 2001; 35(5):331-7. PubMed ID: 11668950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM; Rathi VK; Grauer JN; Ross JS
    Clin Orthop Relat Res; 2016 Apr; 474(4):1053-68. PubMed ID: 26584802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Registry Assessment of Peripheral Interventional Devices (RAPID): Registry assessment of peripheral interventional devices core data elements.
    Jones WS; Krucoff MW; Morales P; Wilgus RW; Heath AH; Williams MF; Tcheng JE; Marinac-Dabic JD; Malone ML; Reed TL; Fukaya R; Lookstein RA; Handa N; Aronow HD; Bertges DJ; Jaff MR; Tsai TT; Smale JA; Zaugg MJ; Thatcher RJ; Cronenwett JL
    J Vasc Surg; 2018 Feb; 67(2):637-644.e30. PubMed ID: 29389426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical devices; patient examination and surgeons' gloves; test procedures and acceptance criteria. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Dec; 71(243):75865-79. PubMed ID: 17294550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An exploratory discussion on biological evaluation and risks for medical devices].
    Sun J
    Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Sep; 30(5):386-7, 382. PubMed ID: 17165574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.